The government is set to begin a nationwide rollout of a long-acting HIV prevention injection, Cabotegravir (CAB-LA), this week, following a successful one-year pilot phase. The rollout aims to ...
The federal Food and Drug Administration has approved Apretude (extended-release cabotegravir), the first long-acting injectable option for HIV prevention. The shots, which are administered by a ...